Mountvector Bio
Annual accounts 2025
micro format, filed on 28-08-2026, 28 days lateTurnover and EBIT margin are not published. The micro format does not require them.
Balance sheet
balance sheet total €180,416 on 31-12-2025Position in the sector
96.6%
Higher than 93% of 88 companies in 2025.
29.77
Higher than 93% of 80 companies in 2025.
-13.9%
Higher than 22% of 83 companies in 2025.
Net result: bottom quarter · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 |
|---|---|---|
| Balance sheet: assets | ||
20/58 |
180,416 | |
29/58 |
180,416 | |
40/41 |
3,699 | |
41 |
3,699 | |
54/58 |
172,904 | |
490/1 |
3,813 | |
| Balance sheet: equity and liabilities | ||
10/49 |
180,416 | |
10/15 |
174,355 | |
10/11 |
199,347 | |
10 |
199,347 | |
100 |
199,347 | |
14 |
-24,992 | |
17/49 |
6,061 | |
42/48 |
6,061 | |
44 |
4,661 | |
440/4 |
4,661 | |
47/48 |
1,400 | |
| Income statement | ||
9900 |
-24,837 | |
9901 |
-24,837 | |
75/76B |
0 | |
75 |
0 | |
65/66B |
156 | |
65 |
156 | |
9903 |
-24,992 | |
9904 |
-24,992 | |
9905 |
-24,992 | |
| Appropriation of the result | ||
9906 |
-24,992 | |
| Document | ||
Source: Annual accounts 2025 at the NBB, filed on 28-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank2025 annual accounts filed 28 days after the deadline. Filed on 28 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00441422.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 28-08-2026 | 2026-00441422 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 |
|---|---|---|
| 174,355 | ||
| 96.6% | ||
| 29.77 | ||
| 0.03 | ||
| -14.3% | ||
| -13.9% |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Insights on Mountvector Bio
Debt's share of the balance-sheet total is 3.4%.